PT  - JOURNAL ARTICLE
AU  - Shuman, Jill
ED  - Shin, Kichul
TI  - Preventing GC-Induced Bone Loss in Women with RA
DP  - 2014  01
TA  - MD Conference Express
PG  - 9--9
VI  - 14
IP  - 51
4099  - http://mdc.sagepub.com/content/14/51/9.short
4100  - http://mdc.sagepub.com/content/14/51/9.full
AB  - Glucocorticoids (GCs) are a commonly prescribed treatment for patients with rheumatoid arthritis (RA). However, the long-term use of these agents in postmenopausal women is associated with an increased risk of osteoporosis and fracture. Therefore, the prevention of GC-induced osteoporosis has become an important goal in treating women with RA. This article presents data from the now complete randomized, double-blind phase 4 clinical trial, Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-Term Steroids [NCT01287533]